Michael Berk, Ph.D., MBBCH, MMED, FF(Psych)SA, FRANCZP
Deakin University School of Medicine
Director, Alfred Deakin Professor of Psychiatry
2015 Colvin Prizewinner for Outstanding Achievement in Mood Disorders Research
<h4>Meet the Scientist</h4>
<p><strong>Prevention of Depression</strong></p>
<p><iframe frameborder="0" height="400" src="https://www.youtube.com/embed/5c7g8Gz_K-o" width="100%"></iframe></p>
Dr. Michael Berk heads the IMPACT Strategic Research Centre at Deakin University and is also an Honorary Professorial Fellow at the Florey Institute of Neuroscience and Mental Health at Orygen’s National Centre of Excellence in Youth Mental Health in the Department of Psychiatry at Melbourne University in Australia. He also serves as a Visiting Professor at the Guiyang Medical University in China and an Honorary Professor in the School of Public Health and Preventive Medicine at Monash University in Australia.
Dr. Michael Berk's major interests are in the discovery and implementation of novel therapies and risk factors and prevention of psychiatric disorders like depression.
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.